Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Pharmacovigilance"" wg kryterium: Temat


Tytuł :
Headache as an Adverse Reaction to the Use of Medication in the Elderly: A Pharmacovigilance Study.
Autorzy :
Monteiro C; UFBI-Pharmacovigilance Unit of Beira Interior, Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal.; Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal.
Dias B; Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal.
Vaz-Patto M; UFBI-Pharmacovigilance Unit of Beira Interior, Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal.; Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal.; CICS UBI-Health Sciences Research Centre-UBI, Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Mar 07; Vol. 18 (5). Date of Electronic Publication: 2021 Mar 07.
Typ publikacji :
Journal Article
MeSH Terms :
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Pharmacovigilance*
Adverse Drug Reaction Reporting Systems ; Aged ; Female ; Headache/chemically induced ; Headache/epidemiology ; Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
Autorzy :
Goldman A; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Israel.; School of Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Bomze D; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Israel.; School of Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel.; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
Dankner R; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Israel.; Unit for Cardiovascular Epidemiology, The Gertner Institute for Epidemiology and Health Policy Research, Ramat Gan, Israel.
Hod H; School of Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel.; Leviev Heart Center, Sheba Medical Center, Ramat Gan, Israel.
Meirson T; Azrieli Faculty of Medicine, Bar-Ilan University, Israel.
Boursi B; School of Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel.; Department of Oncology, Sheba Medical Center, Tel HaShomer, Israel.; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.
Maor E; School of Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel.; Leviev Heart Center, Sheba Medical Center, Ramat Gan, Israel.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Mar; Vol. 87 (3), pp. 1432-1442. Date of Electronic Publication: 2020 Sep 22.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Pharmacovigilance*
Antimalarials/*adverse effects
COVID-19/*drug therapy
Cardiovascular Diseases/*chemically induced
Chloroquine/*adverse effects
Hydroxychloroquine/*adverse effects
Adult ; Aged ; Antimalarials/therapeutic use ; COVID-19/complications ; Cardiovascular Diseases/epidemiology ; Chloroquine/therapeutic use ; Databases, Factual ; Drug Overdose ; Female ; Humans ; Hydroxychloroquine/therapeutic use ; Male ; Middle Aged ; Odds Ratio ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Drug induced stuttering: pharmacovigilance data.
Autorzy :
Trenque T; Reims University Hospitals, Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Reims, France.; Faculty of Medicine, University of Reims Champagne-Ardenne, Reims, France.
Morel A; Reims University Hospitals, Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Reims, France.
Trenque A; Reims University Hospitals, Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Reims, France.
Azzouz B; Reims University Hospitals, Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Reims, France.; Faculty of Medicine, University of Reims Champagne-Ardenne, Reims, France.
Pokaż więcej
Źródło :
Expert opinion on drug safety [Expert Opin Drug Saf] 2021 Mar; Vol. 20 (3), pp. 373-378. Date of Electronic Publication: 2020 Dec 27.
Typ publikacji :
Journal Article
MeSH Terms :
Adverse Drug Reaction Reporting Systems*
Pharmacovigilance*
Drug-Related Side Effects and Adverse Reactions/*epidemiology
Stuttering/*chemically induced
Adolescent ; Adult ; Aged ; Databases, Factual ; Female ; Humans ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
French Pharmacovigilance Public System and COVID-19 Pandemic.
Autorzy :
Grandvuillemin A; Centre régional de Pharmacovigilance, Hôpital François Mitterrand, 14 Rue Paul Gaffarel, BP77908, Dijon, 21079, France. .
Drici MD; Regional Pharmacovigilance Center of Nice, Department of Clinical Pharmacology, Université Côte d'Azur, Nice, France.
Jonville-Bera AP; Regional Pharmacovigilance Center of Tours, Service de Pharmacosurveillance, CHRU, Tours, France.
Micallef J; Regional Pharmacovigilance Center of Marseille, Service Hospitalo-Universitaire de Pharmacologie Clinique et Pharmacovigilance, Assistance Publique Hôpitaux de Marseille, Aix Marseille Université, Institut des Neurosciences des Systèmes, INSERM 1106, Marseille, France.
Montastruc JL; Regional Center of Pharmacovigilance, Pharmacoepidemiology and Drug Information, Service de Pharmacologie Médicale et Clinique, IC 1436 INSERM, Faculty of Medicine, University Hospital, Toulouse, France.
Pokaż więcej
Corporate Authors :
French Pharmacovigilance Network
Źródło :
Drug safety [Drug Saf] 2021 Apr; Vol. 44 (4), pp. 405-408. Date of Electronic Publication: 2020 Dec 28.
Typ publikacji :
Journal Article
MeSH Terms :
Pharmacovigilance*
COVID-19/*epidemiology
Adverse Drug Reaction Reporting Systems/organization & administration ; Antiviral Agents/administration & dosage ; Antiviral Agents/adverse effects ; France/epidemiology ; Humans ; Pandemics ; SARS-CoV-2 ; Time Factors
Czasopismo naukowe
Tytuł :
Pharmacovigilance for chlorhexidine anaphylaxis: a preventable adverse reaction.
Autorzy :
Fernando SL; Royal North Shore Hospital, Sydney, NSW.; University of Sydney, Sydney, NSW.
Capon MJ; Royal North Shore Hospital, Sydney, NSW.
Green SL; Royal North Shore Hospital, Sydney, NSW.
Boyle MJ; John Hunter Hospital, Newcastle, NSW.; University of Newcastle, Newcastle, NSW.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2021 Mar; Vol. 214 (4), pp. 162-163.e1. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Pharmacovigilance*
Anaphylaxis/*prevention & control
Chlorhexidine/*adverse effects
Drug Hypersensitivity/*prevention & control
Aged ; Anaphylaxis/chemically induced ; Drug Hypersensitivity/etiology ; Humans ; Male
Czasopismo naukowe
Tytuł :
A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments.
Autorzy :
Baker EH; St George's, University of London, London, UK.; British Pharmacological Society, London, UK.
Gnjidic D; School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Hamilton, Australia.
Kirkpatrick CMJ; Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Hamilton, Australia.; Centre for Medicine Use and Safety, Monash University, Parkville, Australia.
Pirmohamed M; British Pharmacological Society, London, UK.; MRC Centre for Drug Safety Science and Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK.
Wright DFB; Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Hamilton, Australia.; School of Pharmacy, University of Otago, Dunedin, New Zealand.
Zecharia AY; British Pharmacological Society, London, UK.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Mar; Vol. 87 (3), pp. 707-711. Date of Electronic Publication: 2020 Jun 19.
Typ publikacji :
Editorial
MeSH Terms :
Pharmacovigilance*
Antiviral Agents/*therapeutic use
COVID-19/*drug therapy
Antiviral Agents/adverse effects ; Drug Evaluation, Preclinical ; Humans ; Immunologic Factors/administration & dosage ; Immunologic Factors/therapeutic use ; Pharmacology, Clinical ; Randomized Controlled Trials as Topic ; SARS-CoV-2/drug effects
Opinia redakcyjna
Tytuł :
Impact of literature reports on drug safety signals.
Autorzy :
Ochyra B; Department of Gastroenterology and Internal Diseases, Medical University of Warsaw, Banacha 1a, 02-097, Warsaw, Poland.
Szewczyk M; MS Pharm s.r.o., Praga, Czech Republic.
Przybylkowski A; Department of Gastroenterology and Internal Diseases, Medical University of Warsaw, Banacha 1a, 02-097, Warsaw, Poland. .
Pokaż więcej
Źródło :
Wiener klinische Wochenschrift [Wien Klin Wochenschr] 2021 Mar; Vol. 133 (5-6), pp. 188-193. Date of Electronic Publication: 2020 May 26.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Pharmaceutical Preparations*
Pharmacovigilance*
Databases, Factual ; Humans ; Information Storage and Retrieval ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Adverse drug reactions in elderly: a five-year review of spontaneous reports to the Portuguese pharmacovigilance system.
Autorzy :
Monteiro C; UFBI - HealthSciences to Health Sciences, University of Beira Interior , Covilhã, Portugal.
Duarte AP; UFBI - HealthSciences to Health Sciences, University of Beira Interior , Covilhã, Portugal.; CICS-UBI - HealthSciences Research Centre, University of Beira Interior , Covilhã, Portugal.
Alves G; UFBI - HealthSciences to Health Sciences, University of Beira Interior , Covilhã, Portugal.; CICS-UBI - HealthSciences Research Centre, University of Beira Interior , Covilhã, Portugal.
Pokaż więcej
Źródło :
Expert opinion on drug safety [Expert Opin Drug Saf] 2021 Jan; Vol. 20 (1), pp. 109-118. Date of Electronic Publication: 2020 Dec 21.
Typ publikacji :
Journal Article
MeSH Terms :
Adverse Drug Reaction Reporting Systems*
Pharmacovigilance*
Drug-Related Side Effects and Adverse Reactions/*epidemiology
Hospitalization/*statistics & numerical data
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Portugal ; Severity of Illness Index ; Vulnerable Populations ; Young Adult
Czasopismo naukowe
Tytuł :
Comparative Assessment of the Pharmacovigilance Systems within the Neglected Tropical Diseases Programs in East Africa-Ethiopia, Kenya, Rwanda, and Tanzania.
Autorzy :
Barry A; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden.
Olsson S; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden.
Khaemba C; Pharmacy and Poisons Board, Kenya Lenana Road, P.O. Box 27663-00506 Nairobi, Kenya.
Kabatende J; Rwanda Food and Drugs Authority, Nyarutarama Plaza, KG 9 Avenue Kigali, Rwanda.
Dires T; Ethiopian Food and Drug Authority, Africa Avenue, Kirkos Sub City, P.O. Box 5681 Addis Ababa, Ethiopia.
Fimbo A; Tanzania Medicines and Medical Devices Authority, Off Mandela Road, Mabibo, P.O. Box 77150 Dar Es Salaam, Tanzania.
Minzi O; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P. O. Box 65013 Dar es Salaam, Tanzania.
Bienvenu E; College of Medicine and Health Sciences, University of Rwanda, KK 737 Kigali, Rwanda.
Makonnen E; Department of Pharmacology and Clinical Pharmacy, College of Health Sciences, Addis Ababa University, P.O. Box 9086 Addis Ababa, Ethiopia.; Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT Africa), College of Health Sciences, Addis Ababa University, P.O. Box 9086 Addis Ababa, Ethiopia.
Kamuhabwa A; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P. O. Box 65013 Dar es Salaam, Tanzania.
Oluka M; Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, P.O. Box 19676-00202 Nairobi, Kenya.
Guantai A; Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, P.O. Box 19676-00202 Nairobi, Kenya.
van Puijenbroek E; Pharmacovigilance Centre Lareb, 5237 MH 's-Hertogenbosch, The Netherlands.
Bergman U; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden.
Nkayamba A; Tanzania Medicines and Medical Devices Authority, Off Mandela Road, Mabibo, P.O. Box 77150 Dar Es Salaam, Tanzania.
Mugisha M; College of Medicine and Health Sciences, University of Rwanda, KK 737 Kigali, Rwanda.
Gurumurthy P; Pharmacovigilance and Clinical Trials, Botswana Medicines Regulatory Authority, P.O. Box 505155 Gaborone, Botswana.
Aklillu E; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Feb 17; Vol. 18 (4). Date of Electronic Publication: 2021 Feb 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neglected Diseases*/drug therapy
Neglected Diseases*/epidemiology
Pharmacovigilance*
Ethiopia ; Humans ; Kenya/epidemiology ; Rwanda/epidemiology ; Tanzania/epidemiology
Czasopismo naukowe
Tytuł :
Targeted eco-pharmacovigilance as an optimized management strategy for adverse effects of pharmaceuticals in the environment.
Autorzy :
Wang J; Department of Pharmacology, College of Medicine, Wuhan University of Science and Technology, Wuhan, China.
Li S; Department of Pharmacology, College of Medicine, Wuhan University of Science and Technology, Wuhan, China.
Zhu Y; Department of Pharmacology, College of Medicine, Wuhan University of Science and Technology, Wuhan, China.
Guo J; Department of Pharmacology, College of Medicine, Wuhan University of Science and Technology, Wuhan, China.
Liu J; Department of Pharmacology, College of Medicine, Wuhan University of Science and Technology, Wuhan, China.
He B; Hubei Province Women and Children Hospital, Wuhan, China. Electronic address: .
Pokaż więcej
Źródło :
Environmental toxicology and pharmacology [Environ Toxicol Pharmacol] 2021 Feb; Vol. 82, pp. 103565. Date of Electronic Publication: 2020 Dec 13.
Typ publikacji :
Journal Article
MeSH Terms :
Pharmacovigilance*
Environmental Pollution/*prevention & control
Environmental Monitoring ; Environmental Pollutants ; Humans ; Pharmaceutical Preparations
Czasopismo naukowe
Tytuł :
Putting the "good" into Good Clinical Practice.
Autorzy :
Symons T; University of Sydney, Sydney, NSW.
Webb S; Royal Perth Hospital, Perth, WA.
Zalcberg JR; Monash University, Melbourne, VIC.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2021 Feb; Vol. 214 (2), pp. 62-65.e1. Date of Electronic Publication: 2021 Jan 11.
Typ publikacji :
Journal Article
MeSH Terms :
Patient Selection*
Pharmacovigilance*
Adverse Drug Reaction Reporting Systems/*standards
Clinical Trials as Topic/*standards
Patient Safety/*standards
Guideline Adherence ; Humans
Czasopismo naukowe
Tytuł :
Drug-induced IgA vasculitis in children and adults: Revisiting drug causality using a dual pharmacovigilance-based approach.
Autorzy :
Rasmussen C; National Referral Centre for Systemic and Autoimmune Diseases, Department of Internal Medicine, Cochin Hospital, AP-HP Centre - Université de Paris, Paris, France.
Tisseyre M; Regional Center of Pharmacovigilance, Department of Pharmacology, Cochin Hospital, AP-HP Centre - Université de Paris, Paris, France.
Garon-Czmil J; Department of Clinical Pharmacology and Pharmacovigilance, University Hospital of Nancy Brabois, Vandoeuvre Lès Nancy, France.
Atzenhoffer M; Department of Clinical Pharmacology and Pharmacovigilance, Hospices civils de Lyon, 69424 Lyon, France.
Guillevin L; National Referral Centre for Systemic and Autoimmune Diseases, Department of Internal Medicine, Cochin Hospital, AP-HP Centre - Université de Paris, Paris, France.
Salem JE; Department of Pharmacology, Pitié-Salpêtrière Hospital, AP-HP Sorbonne Université, Paris, France.
Treluyer JM; Regional Center of Pharmacovigilance, Department of Pharmacology, Cochin Hospital, AP-HP Centre - Université de Paris, Paris, France.
Terrier B; National Referral Centre for Systemic and Autoimmune Diseases, Department of Internal Medicine, Cochin Hospital, AP-HP Centre - Université de Paris, Paris, France.
Chouchana L; Regional Center of Pharmacovigilance, Department of Pharmacology, Cochin Hospital, AP-HP Centre - Université de Paris, Paris, France. Electronic address: .
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2021 Jan; Vol. 20 (1), pp. 102707. Date of Electronic Publication: 2020 Nov 14.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Pharmaceutical Preparations*
Pharmacovigilance*
Purpura, Schoenlein-Henoch*
Vasculitis*/chemically induced
Vasculitis*/epidemiology
Adult ; Child ; Humans ; Immunoglobulin A ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Characterization of drug-induced cutaneous lupus: Analysis of 1994 cases using the WHO pharmacovigilance database.
Autorzy :
Kawka L; Service de Rhumatologie, Hôpitaux Universitaires de Strasbourg, Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Centre National de Références des Maladies Systémiques et Autoimmunes Rares Est Sud-Ouest (RESO), Université de Strasbourg, F-67000 Strasbourg, France.
Mertz P; Service de Rhumatologie, Hôpitaux Universitaires de Strasbourg, Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Centre National de Références des Maladies Systémiques et Autoimmunes Rares Est Sud-Ouest (RESO), Université de Strasbourg, F-67000 Strasbourg, France.
Chasset F; APHP, Faculté de Médecine Sorbonne Université, Paris, France.
Lebrun-Vignes B; AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Regional Pharmacovigilance Center, INSERM, Sorbonne Universités, F-75013 Paris, France; EA 7379 EpidermE, Université Paris-Est Créteil, UPEC, Créteil F-94010, France.
Salem JE; AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Regional Pharmacovigilance Center, INSERM, Sorbonne Universités, F-75013 Paris, France.
Arnaud L; Service de Rhumatologie, Hôpitaux Universitaires de Strasbourg, Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Centre National de Références des Maladies Systémiques et Autoimmunes Rares Est Sud-Ouest (RESO), Université de Strasbourg, F-67000 Strasbourg, France. Electronic address: .
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2021 Jan; Vol. 20 (1), pp. 102705. Date of Electronic Publication: 2020 Nov 11.
Typ publikacji :
Letter
MeSH Terms :
Databases, Factual*
Pharmacovigilance*
World Health Organization*
Lupus Erythematosus, Cutaneous/*chemically induced
Lupus Erythematosus, Cutaneous/*epidemiology
Drug-Related Side Effects and Adverse Reactions ; Humans
Opinia redakcyjna
Tytuł :
Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the food and drug administration adverse event reporting system.
Autorzy :
Ali Z; Department of Pharmacy, University of Peshawar , Peshawar, Khyber Pakhtunkhwa, Pakistan.
Ismail M; Department of Pharmacy, University of Peshawar , Peshawar, Khyber Pakhtunkhwa, Pakistan.
Khan F; Department of Pharmacy, University of Peshawar , Peshawar, Khyber Pakhtunkhwa, Pakistan.
Sajid H; Department of Pharmacy, University of Peshawar , Peshawar, Khyber Pakhtunkhwa, Pakistan.
Pokaż więcej
Źródło :
Expert opinion on drug safety [Expert Opin Drug Saf] 2021 Jan; Vol. 20 (1), pp. 101-107. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :
Journal Article
MeSH Terms :
Pharmacovigilance*
Adverse Drug Reaction Reporting Systems/*statistics & numerical data
Histamine H1 Antagonists/*adverse effects
Torsades de Pointes/*chemically induced
Adolescent ; Adult ; Aged ; Algorithms ; Child ; Child, Preschool ; Data Mining ; Databases, Factual ; Female ; Histamine H1 Antagonists/administration & dosage ; Humans ; Infant ; Long QT Syndrome/chemically induced ; Male ; Middle Aged ; Risk Factors ; Torsades de Pointes/epidemiology ; United States ; United States Food and Drug Administration ; Young Adult
Czasopismo naukowe
Tytuł :
[Analysis of reports of otoxicity, with symptoms of tinnitus, in the database of the Spanish Pharmacovigilance System for medicinal products for human use.]
Autorzy :
Lisbona-Alquézar MP; Servicio de Otorrinolaringología. Hospital Royo Villanova. Zaragoza. España.
Lanuza-Giménez J; Departamento de Farmacología y Fisiología. Facultad de Medicina. Universidad de Zaragoza. Zaragoza. España.
Navarro-Pemán MC; Centro de Farmacovigilancia de Aragón. Zaragoza. España.
Esteban-Jiménez Ó; Centro de Salud Sádaba. Zaragoza. España.
Fernández-Alquézar Ó; Gerencia de Urgencias y Emergencias Sanitarias 061 Aragón. Servicio Aragonés de Salud. Zaragoza. España.
Fernández-Liesa R; Servicio de Otorrinolaringología. Hospital Universitario Miguel Servet. Zaragoza. España.
Pokaż więcej
Transliterated Title :
Análisis de las notificaciones de ototoxicidad, con sintomatología de acúfenos, en la base de datos del Sistema Español de Farmacovigilancia de medicamentos de uso humano.
Źródło :
Revista espanola de salud publica [Rev Esp Salud Publica] 2020 Dec 09; Vol. 94. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Drug-Related Side Effects and Adverse Reactions*
Pharmacovigilance*
Adverse Drug Reaction Reporting Systems/*statistics & numerical data
Tinnitus/*chemically induced
Adult ; Aged ; Algorithms ; Databases, Factual ; Disabled Persons ; Female ; Humans ; Male ; Middle Aged ; Pharmaceutical Preparations ; Retrospective Studies ; Spain/epidemiology
Czasopismo naukowe
Tytuł :
A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19.
Autorzy :
Diaby V; College of Pharmacy, HPNP 3317, University of Florida , Gainesville, FL, USA.
Almutairi RD; Department of Pharmaceutical Business and Administration Sciences, MCPHS University , Boston, MA, USA.
Chen Z; College of Pharmacy, HPNP 3317, University of Florida , Gainesville, FL, USA.
Moussa RK; Théorie Économique, Modélisation et Applications (ThEMA), Université de Cergy-Pontoise, France and Ecole Nationale Supérieure de Statistiques et d'Economie Appliquée (ENSEA).
Berthe A; Northwest Territories Government , Yellowknife, Canada.
Pokaż więcej
Źródło :
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2021 Feb; Vol. 21 (1), pp. 159-168. Date of Electronic Publication: 2020 Dec 08.
Typ publikacji :
Journal Article
MeSH Terms :
Pharmacovigilance*
Anti-Bacterial Agents/*adverse effects
Anti-Bacterial Agents/*therapeutic use
Antimalarials/*adverse effects
Antimalarials/*therapeutic use
Arrhythmias, Cardiac/*chemically induced
Azithromycin/*adverse effects
Azithromycin/*therapeutic use
COVID-19/*drug therapy
Adverse Drug Reaction Reporting Systems ; Drug Therapy, Combination ; Electrocardiography/drug effects ; Humans ; Long QT Syndrome/chemically induced ; Long QT Syndrome/epidemiology ; Torsades de Pointes/chemically induced ; Torsades de Pointes/epidemiology ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł :
Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem.
Autorzy :
Fresse A; Department of Clinical Pharmacology, Université Côte d'Azur Medical Center Pasteur hospital, Bât J4, 30, avenue de la Voie-Romaine, CS51069, Nice Cedex 01 06001, France. Electronic address: .
Viard D; Department of Clinical Pharmacology, Université Côte d'Azur Medical Center Pasteur hospital, Bât J4, 30, avenue de la Voie-Romaine, CS51069, Nice Cedex 01 06001, France. Electronic address: .
Romani S; Department of Clinical Pharmacology, Université Côte d'Azur Medical Center Pasteur hospital, Bât J4, 30, avenue de la Voie-Romaine, CS51069, Nice Cedex 01 06001, France. Electronic address: .
Gérard A; Department of Clinical Pharmacology, Université Côte d'Azur Medical Center Pasteur hospital, Bât J4, 30, avenue de la Voie-Romaine, CS51069, Nice Cedex 01 06001, France. Electronic address: .
Lepelley M; RCPV of Grenoble. University of Grenoble Medical Center, Grenoble 38043, France. Electronic address: .
Rocher F; Department of Clinical Pharmacology, Université Côte d'Azur Medical Center Pasteur hospital, Bât J4, 30, avenue de la Voie-Romaine, CS51069, Nice Cedex 01 06001, France. Electronic address: .
Salem JE; INSERM, AP-HP. Sorbonne Université, Clinical Investigation Center, Department of Pharmacology, Pitié-Salpêtrière Hospital, Sorbonne Université, CIC-1901, Paris 75013, France; Departments of Medicine and Pharmacology, Vanderbilt University Medical Center, Nashville, TN, United States of America. Electronic address: .
Drici MD; Department of Clinical Pharmacology, Université Côte d'Azur Medical Center Pasteur hospital, Bât J4, 30, avenue de la Voie-Romaine, CS51069, Nice Cedex 01 06001, France. Electronic address: pharmacovigilance@chu-nice.fr.
Pokaż więcej
Corporate Authors :
French Network of Pharmacovigilance Centers
Źródło :
International journal of cardiology [Int J Cardiol] 2021 Feb 01; Vol. 324, pp. 255-260. Date of Electronic Publication: 2020 Oct 16.
Typ publikacji :
Journal Article
MeSH Terms :
Pharmacovigilance*
COVID-19/*drug therapy
COVID-19/*epidemiology
Cardiotoxicity/*epidemiology
Lopinavir/*administration & dosage
Lopinavir/*adverse effects
Ritonavir/*administration & dosage
Ritonavir/*adverse effects
Aged ; Aged, 80 and over ; COVID-19/diagnosis ; Cardiotoxicity/diagnosis ; Drug Combinations ; Electrocardiography/drug effects ; Electrocardiography/trends ; Female ; France/epidemiology ; HIV Protease Inhibitors/administration & dosage ; HIV Protease Inhibitors/adverse effects ; Humans ; Long QT Syndrome/chemically induced ; Long QT Syndrome/diagnosis ; Long QT Syndrome/epidemiology ; Male ; Middle Aged ; Potassium Channel Blockers/administration & dosage ; Potassium Channel Blockers/adverse effects
Czasopismo naukowe
Tytuł :
[Criminal poisoning in Morocco: data from the Morocco Poison Control and Pharmacovigilance Centre (1980-2014)].
Autorzy :
Boukhorb S; Faculté des Sciences, Université Ibn Tofail, Kénitra, Maroc.
Rhalem N; Centre Antipoison et de Pharmacovigilance du Maroc, Rabat, Maroc.
Hmimou S; Faculté des Sciences, Université Ibn Tofail, Kénitra, Maroc.
Soulaymani A; Faculté des Sciences, Université Ibn Tofail, Kénitra, Maroc.
Mokhtari A; Faculté des Sciences, Université Ibn Tofail, Kénitra, Maroc.
Soulaymani-Bencheikh R; Centre Antipoison et de Pharmacovigilance du Maroc, Rabat, Maroc.; Faculté de Médecine et de Pharmacie, Université Mohammed V, Rabat, Maroc.
Hmimou R; Centre Antipoison et de Pharmacovigilance du Maroc, Rabat, Maroc.
Hami H; Faculté des Sciences, Université Ibn Tofail, Kénitra, Maroc.
Pokaż więcej
Transliterated Title :
Empoisonnement criminel au Maroc: données du Centre Antipoison et de Pharmacovigilance du Maroc, 1980-2014.
Źródło :
The Pan African medical journal [Pan Afr Med J] 2021 Jan 15; Vol. 38, pp. 42. Date of Electronic Publication: 2021 Jan 15 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Crime*
Pharmacovigilance*
Poisoning/*epidemiology
Poisons/*administration & dosage
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Female ; Humans ; Male ; Middle Aged ; Morocco/epidemiology ; Pesticides/poisoning ; Plant Poisoning/epidemiology ; Poison Control Centers/statistics & numerical data ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor's Perspective.
Autorzy :
Beyzarov E; Worldwide Medical and Safety, Worldwide Research and Development, Pfizer Inc, 100 US-206, Peapack, NJ, 07977, USA. .
Chen Y; Worldwide Medical and Safety, Worldwide Research and Development, Pfizer Inc, 100 US-206, Peapack, NJ, 07977, USA.
Julg R; Information Management Operations Center of Excellence, Global Product Development Pfizer Inc, Peapack, NJ, USA.
Naim K; Worldwide Medical and Safety, Worldwide Research and Development, Pfizer Inc, 100 US-206, Peapack, NJ, 07977, USA.
Shah J; Worldwide Medical and Safety, Worldwide Research and Development, Pfizer Inc, 100 US-206, Peapack, NJ, 07977, USA.
Gregory WW; Worldwide Medical and Safety, Worldwide Research and Development, Pfizer Inc, 100 US-206, Peapack, NJ, 07977, USA.
Ayoub A; Worldwide Medical and Safety, Worldwide Research and Development, Pfizer Inc, 100 US-206, Peapack, NJ, 07977, USA.
Caubel P; Worldwide Medical and Safety, Worldwide Research and Development, Pfizer Inc, 100 US-206, Peapack, NJ, 07977, USA.
Pokaż więcej
Źródło :
Drug safety [Drug Saf] 2021 Jan; Vol. 44 (1), pp. 95-105. Date of Electronic Publication: 2020 Dec 22.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Pharmacovigilance*
Adverse Drug Reaction Reporting Systems/*trends
COVID-19/*epidemiology
Drug Industry/*trends
Drug-Related Side Effects and Adverse Reactions/*epidemiology
Global Health/*trends
Adverse Drug Reaction Reporting Systems/standards ; Anticoagulants/adverse effects ; Antimalarials/adverse effects ; Antiviral Agents/adverse effects ; COVID-19/drug therapy ; Databases, Factual/standards ; Databases, Factual/trends ; Drug Industry/standards ; Drug-Related Side Effects and Adverse Reactions/diagnosis ; Global Health/standards ; Humans ; Immunosuppressive Agents/adverse effects ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Drug-Induced Hearing Loss in Children: An Analysis of Spontaneous Reports in the French PharmacoVigilance Database.
Autorzy :
Gainville A; Service de Pharmacologie Médicale et Clinique, Centre Régional de Pharmacovigilance, Pharmacoépidémiologie et Informations sur le Médicament, INSERM U 1027, CIC INSERM 1436, Centre Hospitalier Universitaire et Faculté de Médecine de Toulouse, France, 37 Allées Jules Guesde, 31000, Toulouse, France.
Rousseau V; Service de Pharmacologie Médicale et Clinique, Centre Régional de Pharmacovigilance, Pharmacoépidémiologie et Informations sur le Médicament, INSERM U 1027, CIC INSERM 1436, Centre Hospitalier Universitaire et Faculté de Médecine de Toulouse, France, 37 Allées Jules Guesde, 31000, Toulouse, France.
Kaguelidou F; Centre d'Investigation Clinique, INSERM CIC1426, Hôpital Robert Debré, 48, boulevard Sérurier, 75019, Paris, France.
Gervoise MB; Service de pharmacologie clinique et pharmacovigilance, centre régional de pharmacovigilance Marseille Provence Corse, hôpital Sainte-Marguerite, Hôpitaux de Marseille, 13009, Marseille, France.
Michot J; Centre Régional de Pharmacovigilance, Saint Antoine Hôpital (APHP), Paris, France.
Pizzoglio-Bellaudaz V; Service Hospitalo-Universitaire de Pharmacotoxicologie, Centre de Pharmacovigilance, Hospices Civils de Lyon, CHU-Lyon, Lyon, France.
Chebane L; Service de Pharmacologie Médicale et Clinique, Centre Régional de Pharmacovigilance, Pharmacoépidémiologie et Informations sur le Médicament, INSERM U 1027, CIC INSERM 1436, Centre Hospitalier Universitaire et Faculté de Médecine de Toulouse, France, 37 Allées Jules Guesde, 31000, Toulouse, France.
Weckel A; Service d'ORL pédiatrique, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Montastruc JL; Service de Pharmacologie Médicale et Clinique, Centre Régional de Pharmacovigilance, Pharmacoépidémiologie et Informations sur le Médicament, INSERM U 1027, CIC INSERM 1436, Centre Hospitalier Universitaire et Faculté de Médecine de Toulouse, France, 37 Allées Jules Guesde, 31000, Toulouse, France.
Durrieu G; Service de Pharmacologie Médicale et Clinique, Centre Régional de Pharmacovigilance, Pharmacoépidémiologie et Informations sur le Médicament, INSERM U 1027, CIC INSERM 1436, Centre Hospitalier Universitaire et Faculté de Médecine de Toulouse, France, 37 Allées Jules Guesde, 31000, Toulouse, France. .
Pokaż więcej
Źródło :
Paediatric drugs [Paediatr Drugs] 2021 Jan; Vol. 23 (1), pp. 87-93. Date of Electronic Publication: 2020 Nov 17.
Typ publikacji :
Journal Article
MeSH Terms :
Pharmacovigilance*
Adverse Drug Reaction Reporting Systems/*standards
Hearing Loss/*chemically induced
Adolescent ; Child ; Child, Preschool ; Databases, Factual ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies